Anne Gallay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anne Gallay has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Francis Mégraud
Centre National de Référence des Campylobacter et Helicobacter , Bordeaux, France
2 shared publicationsHenriette de Valk
Département Maladies Infectieuses , Saint-Maurice
2 shared publications- Valérie Prouzet-Mauléon
University of Bordeaux, CRISP'edit, TBMCore UAR CNRS 3427, US Inserm 005, F-33000 Bordeaux, France
2 shared publications - Alessandra Falchi
Institut National de la Santé et de la Recherche Médicale, UMR-S 707, F-75012 Paris, France
1 shared publication - Andrea Lasserre
UPMC Univ Paris 06, 27, Rue de Chaligny, 75571 Paris Cedex 12, France
1 shared publication Christine Camou
Centre National de Référence des Campylobacter and Helicobacter, Bordeaux, France
1 shared publication
Latest Publications
- Open Access
- 10 October 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 251
A three-source capture-recapture estimate of the number of new HIV diagnoses in children in France from 2003–2006 with multiple imputation of a variable of heterogeneous catchability
Nearly all HIV infections in children worldwide are acquired through mother-to-child transmission (MTCT) during pregnancy, labour, delivery or breastfeeding. The objective of our study was to estimate the number and rate of new HIV diagnoses in children less than 13 years of age in mainland France from 2003–2006.
- 10 October 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 251
Open AccessA three-source capture-recapture estimate of the number of new HIV diagnoses in children in France from 2003–2006 with multiple imputation of a variable of heterogeneous catchability
Nearly all HIV infections in children worldwide are acquired through mother-to-child transmission (MTCT) during pregnancy, labour, delivery or breastfeeding. The objective of our study was to estimate the number and rate of new HIV diagnoses in children less than 13 years of age in mainland France from 2003–2006.
- Open Access
- 18 May 2011
- Published by Springer Nature in BMC Family Practice
- Vol. 12 (1) , 35
A survey of primary care physician practices in antibiotic prescribing for the treatment of uncomplicated male gonoccocal urethritis
The development of resistance to antimicrobial therapy by Neisseria gonorrhoeae causes on-going problems for individual case management of gonorrhoea. Surveillance data about N. gonorrhoeae have indicated an increase in the incidence of gonorrhoea in France in 2006. As a consequence of the development of antibiotic resistance in N. gonorrhoeae, French guidelines excluded fluoroquinolones as a standard treatment for N. gonorrhoeae. Ceftriaxone became the recommended treatment, associated with azithromycin for Clamydia trachomatis infection. Our aim was to describe the practice patterns of general practitioners (GPs) in managing the antibiotic treatment of patients with symptoms suggestive of uncomplicated male urethritis.
- 18 May 2011
- Published by Springer Nature in BMC Family Practice
- Vol. 12 (1) , 35
Open AccessA survey of primary care physician practices in antibiotic prescribing for the treatment of uncomplicated male gonoccocal urethritis
The development of resistance to antimicrobial therapy by Neisseria gonorrhoeae causes on-going problems for individual case management of gonorrhoea. Surveillance data about N. gonorrhoeae have indicated an increase in the incidence of gonorrhoea in France in 2006. As a consequence of the development of antibiotic resistance in N. gonorrhoeae, French guidelines excluded fluoroquinolones as a standard treatment for N. gonorrhoeae. Ceftriaxone became the recommended treatment, associated with azithromycin for Clamydia trachomatis infection. Our aim was to describe the practice patterns of general practitioners (GPs) in managing the antibiotic treatment of patients with symptoms suggestive of uncomplicated male urethritis.
- Open Access
- 15 May 2008
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (10) , 1477-1484
Risk Factors for Acquiring SporadicCampylobacterInfection in France: Results from a National Case‐Control Study
Background. To better document the risk factors for sporadic Campylobacter infection in France, we conducted a national case-control study from Septe
- 15 May 2008
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (10) , 1477-1484
Open AccessRisk Factors for Acquiring SporadicCampylobacterInfection in France: Results from a National Case‐Control Study
Background. To better document the risk factors for sporadic Campylobacter infection in France, we conducted a national case-control study from Septe
- Open Access
- 1 February 2007
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 13 (2) , 259-266
Campylobacter Antimicrobial Drug Resistance among Humans, Broiler Chickens, and Pigs, France
We describe isolates from human Campylobacter infection in the French population and the isolates' antimicrobial drug resistance patterns since 1986 and compare the trends with those of isolates from broiler chickens and pigs from 1999 to 2004. Among 5,685 human Campylobacter isolates, 76.2% were C. jejuni, 17.2% C. coli, and 5.0% C. fetus. Resistance to nalidixic acid increased from 8.2% in 1990 to 26.3% in 2004 (p<10-3), and resistance to ampicillin was high over time. Nalidixic acid resistance was greater for C. coli (21.3%) than for C. jejuni (14.9%, p<10-3). C. jejuni resistance to ciprofloxacin in broilers decreased from 31.7% in 2002 to 9.0% in 2004 (p = 0.02). The patterns of resistance to quinolones and fluoroquinolones were similar between 1999 and 2004 in human and broiler isolates for C. jejuni. These results suggest a potential benefit of a regulation policy limiting use of antimicrobial drugs in food animals.
- 1 February 2007
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 13 (2) , 259-266
Open AccessCampylobacter Antimicrobial Drug Resistance among Humans, Broiler Chickens, and Pigs, France
We describe isolates from human Campylobacter infection in the French population and the isolates' antimicrobial drug resistance patterns since 1986 and compare the trends with those of isolates from broiler chickens and pigs from 1999 to 2004. Among 5,685 human Campylobacter isolates, 76.2% were C. jejuni, 17.2% C. coli, and 5.0% C. fetus. Resistance to nalidixic acid increased from 8.2% in 1990 to 26.3% in 2004 (p<10-3), and resistance to ampicillin was high over time. Nalidixic acid resistance was greater for C. coli (21.3%) than for C. jejuni (14.9%, p<10-3). C. jejuni resistance to ciprofloxacin in broilers decreased from 31.7% in 2002 to 9.0% in 2004 (p = 0.02). The patterns of resistance to quinolones and fluoroquinolones were similar between 1999 and 2004 in human and broiler isolates for C. jejuni. These results suggest a potential benefit of a regulation policy limiting use of antimicrobial drugs in food animals.